"Pseudopolyps Do Not Predict Neoplasia In Patients With IBD" – Alex Young
An analysis of 20 years of data — published in Gastroenterology — found that pseudopolyps are not associated with advanced colorectal neoplasia in patients with inflammatory bowel disease. Researchers feel that their findings could impact how patients with IBD undergo screening colonoscopies, particularly in Europe, where current guidelines recommend patients with pseudopolyps receive screenings more frequently. “This is very good news for the IBD patients with pseudopolyps, as their surveillance colonoscopies will likely be affected by these results,” said Steven Itzkowitz, MD, professor of medicine, gastroenterology and oncological sciences at the Icahn School of Medicine at Mount Sinai. “We hope that doctors treating these IBD patients would be less fearful of colon cancer risk in a colon with pseudopolyps and forego shortened intervals of surveillance as a result of our findings, lending to improved quality of life and lower health care costs.”
— Steven H. Itzkowitz, MD, Professor, Medicine, Gastroenterology, Oncological Sciences, Director, GI Fellowship Program, Icahn School of Medicine at Mount Sinai